- $105.21m
- $99.96m
- $32.38m
Brief: Stereotaxis Files Prospectus For Resale Of Up To 12.2 Million Shares
Brief: Stereotaxis Inc - Announced That Kimberly Peery Has Been Appointed Stereotaxis Chief Financial Officer
Brief: Stereotaxis Announces Uplisting To NYSE American
Brief: Stereotaxis And Johnson & Johnson's Biosense Webster Extend Development Alliance And Supply Agreement
Brief: Stereotaxis reports Q2 revenue $8.5 million
Brief: Stereotaxis reports Q2 loss per share $0.11
Brief: Stereotaxis releases second generation V-CAS deflect system in Europe
Brief: Stereotaxis reports Q1 loss per share $0.11
Brief: Stereotaxis Q3 loss per share $0.05
Brief: Stereotaxis announces Ex-warrants date of September 15, 2015 for warrants offering
Brief: Stereotaxis announces warrants offering
Brief: Stereotaxis says findings support benefits of niobe system's maneuverability in difficult to reach anatomical areas
Brief: Stereotaxis Q2 loss per share $0.07
Brief: Stereotaxis Q1 loss per share $0.15
Brief: Stereotaxis elects Duane DeSisto to Board of Directors
Brief: Stereotaxis extends Silicon Valley bank credit facility by 3 years
Brief: Stereotaxis Q4 earnings per share $0.04
Brief: Stereotaxis announces results from atrial fibrillation treatment study
Brief: Stereotaxis receives FDA clearance of Vdrive with v-Cas system